Reference
Druyan A, et al. Effect of interleukin-1 inhibition in a cohort of patients with colchicine-resistant familial Mediterranean fever treated consecutively with anakinra and canakinumab. Clinical and Experimental Rheumatology 39 (Suppl. 132): S75-S79, No. 5, 2021. Available from: URL: http://doi.org/10.55563/clinexprheumatol/rrr9zd
Rights and permissions
About this article
Cite this article
Anakinra/colchicine. Reactions Weekly 1963, 46 (2023). https://doi.org/10.1007/s40278-023-42102-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-023-42102-1